Screener
Ironwood Pharmaceuticals IRWD Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's total equity?
- Ironwood Pharmaceuticals (IRWD) reported total equity of -$161.84M in Q2 2026.
- How has Ironwood Pharmaceuticals's total equity changed year-over-year?
- Ironwood Pharmaceuticals's total equity increased by 47.5% year-over-year, from -$308.16M to -$161.84M.
- What is the long-term trend for Ironwood Pharmaceuticals's total equity?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's total equity has grown at a 33.1% compound annual growth rate (CAGR), from $62.64M to -$261.84M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Ironwood Pharmaceuticals's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude